Merck Invests US$354 million (€300 million) to Open Science Research Centre in Germany
Introduction:
Merck invests US$354 million (€300 million) to open new life science research centre in Germany.
Features:
The advanced research centre focuses on conducting research into manufacturing antibodies, mRNA applications, and other biotechnological products.
Spanning approximately 18,000 square metres, the centre promotes collaboration across departments in a contemporary, open workspace. The carefully engineered facades, alongside the incorporation of green roofs, play a pivotal role in conserving energy and enhancing the microclimate.
It serves as a hub for research into critical technologies including the development of raw materials and processes for manufacturing antibodies, recombinant proteins, and viral vectors.
Additionally, the centre facilitates research into chemical substance separation, identification, and quantification within samples, as well as research along the mRNA value chain.
By the beginning of 2027, the centre will accommodate around 550 employees.
Specifications:
Name Merck
Type New Construction
Budget US$354 million (€300 million)
